Biopharmaceutical Manufacturing is the innovative process of producing therapeutic drugs and pharmaceuticals using living cells and biological systems. This cutting-edge field combines biology, chemistry, and engineering to create complex molecules that serve as the foundation for advanced medical treatments. Unlike traditional pharmaceuticals, biopharmaceuticals are derived from living organisms, such as bacteria, yeast, or mammalian cells, employing genetic engineering and bioprocessing techniques. Biopharmaceutical Manufacturing plays a pivotal role in delivering biologics, monoclonal antibodies, vaccines, and other personalized medicines, contributing significantly to modern healthcare. Its precision, scalability, and focus on quality make it a cornerstone in the development of advanced therapies, ultimately enhancing patient outcomes. This dynamic field continuously evolves, harnessing the power of science and technology to drive medical innovation forward.
In the realm of Biopharmaceutical Manufacturing, several crucial areas shape the landscape of this dynamic field. Here are the primary focus areas within Biopharmaceutical Manufacturing:
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Biocompatibility and subcutaneous host response to silk fibroin–chitosan composite plugs: Progress toward biodegradable implant materials
Luis Jesus Villarreal Gomez, Universidad Autónoma de Baja California, Mexico